Transforming protein engineering on a global scale.
Founded in 2020, Absea is one of the fastest-growing biotech companies, with over 250 employees worldwide. Our cutting-edge platform enables rapid development of soluble proteins and monoclonal antibodies, supporting up to 1,000 new projects each month.
In partnership with leaders in life sciences, we have built a synthetic library of 14,000 soluble proteins, covering 70% of the human proteome, and we continue to expand our portfolio .Our validated monoclonal antibodies are designed for diverse applications and are ready for broad market supply.
From our Innovation Center in Berlin, Manufacturing Centers in China, to our Commercialization Center in the Bay Area, we support protein scientists and industry partners engaged in AI-driven protein design, diagnostics, and drug development.
At Absea, we strive to be the long-term partner of choice for the world’s leading labs, companies, and service providers.
Let’s engineer the future together. Connect with us to explore how Absea can power your research and discovery.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Absea Biotechnology Gmbh, Building D85, Robert-Roessle-Str. 10, Berlin,13125,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.absea.bio
- Keywords
- monoclonal antibody, protein, proteomics, CRO, reagent.
- HQ
- Berlin
Absea Biotech Questions
Absea Biotech's website is http://www.absea.bio
Absea Biotech's LinkedIn profile is https://de.linkedin.com/company/absea
Absea Biotech has
19 employees.
View email and phone details for 19
employees at Absea Biotech.
Absea Biotech's industry is
Biotechnology Research
Absea Biotech's categories are Biotechnology Research
Absea Biotech's founding year is 2020
